We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
Cap. Flow
-$1.63B
Cap. Flow %
-16.3%
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$173M
2
EBAY icon
eBay
EBAY
+$149M
3
ZTS icon
Zoetis
ZTS
+$127M
4
TFX icon
Teleflex
TFX
+$108M
5
TMO icon
Thermo Fisher Scientific
TMO
+$98.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Consumer Discretionary 18.46%
3 Technology 13.47%
4 Financials 11.57%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
551
Parker-Hannifin
PH
$124B
$2.53M 0.03%
19,500
-996
-5% -$180K
SLGN icon
552
Silgan Holdings
SLGN
$4.92B
$2.53M 0.03%
+87,139
New +$2.62M
FMS icon
553
Fresenius Medical Care
FMS
$13.4B
$2.51M 0.03%
76,485
-26,791
-26% -$996K
KDP icon
554
Keurig Dr Pepper
KDP
$41B
$2.5M 0.03%
103,115
-70,315
-41% -$1.9M
HIMS icon
555
Hims & Hers Health
HIMS
$7B
$2.5M 0.03%
249,996
FTAI icon
556
FTAI Aviation
FTAI
$22B
$2.5M 0.02%
+356,265
New +$5.04M
ADMA icon
557
ADMA Biologics
ADMA
$1.97B
$2.48M 0.02%
+862,392
New +$2.98M
BXP icon
558
Boston Properties
BXP
$11B
$2.48M 0.02%
+26,930
New +$3.47M
DFPHU
559
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
$2.48M 0.02%
+250,000
New +$2.46M
NAVI icon
560
Navient
NAVI
$809M
$2.48M 0.02%
326,746
-28,056
-8% -$335K
EXC icon
561
Exelon
EXC
$48.2B
$2.47M 0.02%
94,144
+26,451
+39% +$832K
CCAC.U
562
DELISTED
CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va
CCAC.U
$2.46M 0.02%
+250,000
New +$2.5M
TBRG
563
DELISTED
TruBridge
TBRG
$2.46M 0.02%
110,705
-15,329
-12% -$394K
BLK icon
564
Blackrock
BLK
$165B
$2.46M 0.02%
+5,583
New +$2.75M
CTB
565
DELISTED
Cooper Tire & Rubber Co.
CTB
$2.45M 0.02%
+150,561
New +$3.75M
UFPI icon
566
UFP Industries
UFPI
$4.98B
$2.45M 0.02%
+65,941
New +$3.03M
SBAC icon
567
SBA Communications
SBAC
$18.3B
$2.45M 0.02%
9,077
-17,323
-66% -$4.57M
LPLA icon
568
LPL Financial
LPLA
$26.5B
$2.45M 0.02%
44,943
-13,171
-23% -$1.06M
IPGP icon
569
IPG Photonics
IPGP
$3.81B
$2.44M 0.02%
+22,094
New +$2.89M
NDLS icon
570
Noodles & Co
NDLS
$84M
$2.41M 0.02%
64,020
+21,241
+50% +$1.13M
ASND icon
571
Ascendis Pharma A/S
ASND
$16.6B
$2.39M 0.02%
21,246
+19,311
+998% +$2.51M
DOC icon
572
Healthpeak Properties
DOC
$15.5B
$2.38M 0.02%
+99,800
New +$3.25M
EFOR
573
Everforth Inc
EFOR
$884M
$2.38M 0.02%
+67,311
New +$3.81M
ABR icon
574
Arbor Realty Trust
ABR
$977M
$2.37M 0.02%
483,235
-407,307
-46% -$4.98M
SAIA icon
575
Saia
SAIA
$11.2B
$2.37M 0.02%
+32,159
New +$2.82M

Similar funds

Marshall Wace's Q1 2020 Portfolio in Review

As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.

  • Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
  • Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
  • Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
  • Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
  • Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
  • Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.